Satellite Healthcare Names Longtime Executive Leader Bernadette Vincent as Its New President
January 11, 2021 13:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Satellite Healthcare, the leading nonprofit dialysis provider, today announced Chief Operating Officer Bernadette Vincent has been promoted to...
Apellis to Present Data on APL-2 in Complement 3 Glomerulopathy at ASN Kidney Week 2019
October 11, 2019 16:01 ET
|
Apellis Pharmaceuticals, Inc.
Company also provides an update on plans in nephrology CRESTWOOD, Ky. and WALTHAM Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq: APLS), a clinical-stage...
Retrophin Announces Appointment of Peter Heerma as Chief Commercial Officer
October 01, 2019 16:30 ET
|
Retrophin, Inc.
SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Peter Heerma as chief commercial officer, effective immediately. In this newly created...
Global Urology Devices Market to Witness a CAGR of 7.63% during 2018-2024
March 27, 2019 07:12 ET
|
Energias Market Research
NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Global urology devices market is likely to augment from USD 30.9 billion in 2017, and is expected to reach USD 51.7 billion by 2024, witnessing a CAGR of...
National Gout Awareness Day: American Kidney Fund Highlights Connection Between Gout and Kidney Disease
May 22, 2018 11:15 ET
|
American Kidney Fund
ROCKVILLE, Md., May 22, 2018 (GLOBE NEWSWIRE) -- Tuesday, May 22, is National Gout Awareness Day and the American Kidney Fund (AKF) is joining a nationwide effort to educate people about the...
Horizon Pharma plc Presents Results from an Open-Label Study on the Use of PROCYSBI® (cysteamine bitartrate) Delayed-Release Capsules in Treatment-Naïve Children Younger than 6 Years of Age
November 04, 2017 11:00 ET
|
Horizon Pharma plc
DUBLIN, Ireland, Nov. 04, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
Horizon Pharma plc Announces Poster Presentation on KRYSTEXXA® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017
November 03, 2017 11:00 ET
|
Horizon Pharma plc
DUBLIN, Ireland, Nov. 03, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
UPDATE -- Clinipace Worldwide Executive Joins Board of Kidney Health Initiative
October 27, 2017 09:42 ET
|
Clinipace Worldwide
MORRISVILLE, N.C., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Hampton Corley, Chief Business Officer of Clinipace Worldwide, a global full-service clinical research organization (CRO), has been appointed to...
Clinipace Worldwide Executive Joins Board of Kidney Health Initiative
October 27, 2017 08:38 ET
|
Clinipace Worldwide
MORRISVILLE, N.C., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Hampton Corley, Chief Business Officer of Clinipace Worldwide, a global full-service clinical research organization (CRO), has been appointed to...
Satellite Healthcare Awards $800,000 in Applied Pragmatic Clinical Research Grants
October 04, 2017 15:42 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today awarded $800,000 in Applied Pragmatic Clinical Research Grants to four...